Cargando…
Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium
Asthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main pur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386066/ https://www.ncbi.nlm.nih.gov/pubmed/37513942 http://dx.doi.org/10.3390/ph16071030 |
_version_ | 1785081568520306688 |
---|---|
author | Biset, Natacha Lelubre, Mélanie Pochet, Stéphanie De Vriese, Carine |
author_facet | Biset, Natacha Lelubre, Mélanie Pochet, Stéphanie De Vriese, Carine |
author_sort | Biset, Natacha |
collection | PubMed |
description | Asthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main purpose of this study was to assess medication adherence and persistence with inhaled medications for chronic treatment of asthma and COPD, as well as to evaluate the factors influencing this adherence. Medication adherence was measured from January 2013 to December 2016 using continuous multiple-interval measures of medication availability (CMA). Persistence was evaluated by treatment episodes (TE). We analyzed the influence of different factors on CMA such as sex, age, type of device, and the realization of the “new medicines service” (NMS), introduced in Belgium in October 2013 to support patients in adhering to their treatment. We also analyzed the consumption of these inhaled medications within the Belgian population and compared them with the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations. Medication adherence varied greatly between the different pharmacological classes: inhaled corticosteroids (ICS) alone or in combination with long-acting beta agonists (LABA) had the lowest medication adherence and persistence, while adherence was highest for the long-acting muscarinic antagonists (LAMA) and LABA/LAMA associations. The NMS seemed to have a positive impact on medication adherence, although few patients completed the two guidance interviews offered by the service. In addition, only a minority of the targeted patients took advantage of this new service. |
format | Online Article Text |
id | pubmed-10386066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103860662023-07-30 Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium Biset, Natacha Lelubre, Mélanie Pochet, Stéphanie De Vriese, Carine Pharmaceuticals (Basel) Article Asthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main purpose of this study was to assess medication adherence and persistence with inhaled medications for chronic treatment of asthma and COPD, as well as to evaluate the factors influencing this adherence. Medication adherence was measured from January 2013 to December 2016 using continuous multiple-interval measures of medication availability (CMA). Persistence was evaluated by treatment episodes (TE). We analyzed the influence of different factors on CMA such as sex, age, type of device, and the realization of the “new medicines service” (NMS), introduced in Belgium in October 2013 to support patients in adhering to their treatment. We also analyzed the consumption of these inhaled medications within the Belgian population and compared them with the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations. Medication adherence varied greatly between the different pharmacological classes: inhaled corticosteroids (ICS) alone or in combination with long-acting beta agonists (LABA) had the lowest medication adherence and persistence, while adherence was highest for the long-acting muscarinic antagonists (LAMA) and LABA/LAMA associations. The NMS seemed to have a positive impact on medication adherence, although few patients completed the two guidance interviews offered by the service. In addition, only a minority of the targeted patients took advantage of this new service. MDPI 2023-07-20 /pmc/articles/PMC10386066/ /pubmed/37513942 http://dx.doi.org/10.3390/ph16071030 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Biset, Natacha Lelubre, Mélanie Pochet, Stéphanie De Vriese, Carine Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title_full | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title_fullStr | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title_full_unstemmed | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title_short | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
title_sort | asthma and copd: comparison with international guidelines and medication adherence in belgium |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386066/ https://www.ncbi.nlm.nih.gov/pubmed/37513942 http://dx.doi.org/10.3390/ph16071030 |
work_keys_str_mv | AT bisetnatacha asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT lelubremelanie asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT pochetstephanie asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT devriesecarine asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium |